DANIEL LYNCH - 15 Jun 2021 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Director
Signature
/s/ Jason F. Cole, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 16:08:31 UTC
Previous filing
21 May 2021
Next filing
18 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +4,353 +55% $0.000000 12,312 15 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +7,000 $0.000000 7,000 15 Jun 2021 Common Stock 7,000 $32.83 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units for common stock vest 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders.
F2 This option vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders.